Filing Details

Accession Number:
0001035443-22-000176
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-29 16:37:37
Reporting Period:
2022-06-27
Accepted Time:
2022-06-29 16:37:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1697532 Applied Therapeutics Inc. APLT Real Estate Investment Trusts (6798) MD
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1035443 Alexandria Real Estate Equities, Inc. 26 North Euclid Avenue
Pasadena CA 91101
No No Yes No
1722024 Alexandria Venture Investments, Llc 26 North Euclid Avenue
Pasadena CA 91101
No No Yes No
1776437 Alexandria Equities No. 7, Llc 26 North Euclid Avenue
Pasadena CA 91101
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-27 1,435,000 $1.00 2,378,977 No 4 P Indirect By subsidiary
Common Stock Acquisiton 2022-06-27 2,065,000 $1.00 4,555,077 No 4 P Indirect By subsidiary
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By subsidiary
No 4 P Indirect By subsidiary
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Pre-Funded Warrant Acquisiton 2022-06-27 615,000 $1.00 615,000 $0.00
Common Stock Pre-Funded Warrant Acquisiton 2022-06-27 885,000 $1.00 885,000 $0.00
Common Stock Common Stock Warrant Acquisiton 2022-06-27 2,050,000 $0.00 2,050,000 $1.00
Common Stock Common Stock Warrant Acquisiton 2022-06-27 2,950,000 $0.00 2,950,000 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
615,000 No 4 P Indirect
885,000 No 4 P Indirect
2,050,000 No 4 P Indirect
2,950,000 No 4 P Indirect
Footnotes
  1. These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant).
  2. These securities are held directly by Alexandria Equities No. 7, LLC ("AE7"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
  3. These securities are held directly by Alexandria Venture Investments, LLC ("AVI"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
  4. The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise.
  5. The Common Stock Warrants are exercisable immediately and will expire five years from the date of issuance. The Common Stock Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise.